对于eGFR值的预测模型,指导慢性脏疾病中血液透析准备的最佳时间
Geo Neul Park1, Yoonwon Choi1, Ji Eun Moon2
1Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, 170, Jomaru-ro, Bucheon 14584, Republic of Korea.
Biomedicines
|December 30, 2025
概括
在慢性病 (CKD) 中预测血液透析准备的最佳时间是复杂的. 这项研究确定了关键因素,并开发了一个模型来指导个性化末期病 (ESKD) 规划,以获得更好的患者结果.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 内部医学 内部医学
- 临床预测模型临床预测模型
背景情况:
- 慢性病 (CKD) 的进展涉及多种因素,使最佳的血液透析准备时间具有挑战性.
- 开始置换疗法的准确时机对于患者的治疗和结果至关重要.
研究的目的:
- 为了确定末期病 (ESKD) 进展的预测因素.
- 开发和验证用于指导慢性病患者血液透析准备时间的预测模型.
主要方法:
- 对507名慢性脏病患者的回顾性分析,这些患者进展到ESKD,需要进行血液透析.
- 在血液透析前6个月 (eGFR_6M) 估计的淋巴膜过率 (eGFR) 和其下降轨迹的评估.
- 使用临床预测因素开发和验证回归模型.
主要成果:
- 平均eGFR_6M为11.7mL/min/1.73m2;糖尿病患者 (DM),心血管疾病患者 (CVD) 和低蛋白血症患者的平均eGFR_6M高于此.
- 在患有DM,肝硬化 (LC) 和脏范围蛋白尿症的患者中观察到更快的eGFR下降.
- 一个结合性别,移动性,DM,CVD,射出分数,BUN和酸盐的预测模型显示了70-75%的P30性能.
结论:
- 开发的模型为科医生提供了一个客观的参考时间透析准备.
- 可以支持个性化ESKD生命规划,可能改善患者的治疗结果.
- 识别预测因素有助于主动管理CKD向ESKD的进展.
相关概念视频
01:28Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration
166
Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
166
01:28Chronic Kidney Disease III: Interprofessional Care
319
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
319
01:25Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
186
In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...
186
01:25Chronic Kidney Disease I: Introduction
536
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
536
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
242
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
242
01:11Renal Failure: Dose Adjustments
401
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
401